105 related articles for article (PubMed ID: 25634678)
1. Advanced glycation end products induce glomerular endothelial cell hyperpermeability by upregulating matrix metalloproteinase activity.
Luo P; Peng H; Li C; Ye Z; Tang H; Tang Y; Chen C; Lou T
Mol Med Rep; 2015 Jun; 11(6):4447-53. PubMed ID: 25634678
[TBL] [Abstract][Full Text] [Related]
2. Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling.
Takeshita T; Nakagawa S; Tatsumi R; So G; Hayashi K; Tanaka K; Deli MA; Nagata I; Niwa M
Mol Cell Neurosci; 2014 May; 60():1-9. PubMed ID: 24472843
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1.
Peng H; Luo P; Li Y; Wang C; Liu X; Ye Z; Li C; Lou T
PLoS One; 2013; 8(11):e80009. PubMed ID: 24244596
[TBL] [Abstract][Full Text] [Related]
4. Synergistic regulation of endothelial tight junctions by antioxidant (Se) and polyunsaturated lipid (GLA) via Claudin-5 modulation.
Martin TA; Das T; Mansel RE; Jiang WG
J Cell Biochem; 2006 Aug; 98(5):1308-19. PubMed ID: 16514648
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
[TBL] [Abstract][Full Text] [Related]
6. Ethanol-induced lymphatic endothelial cell permeability via MAP-kinase regulation.
Herrera M; Molina P; Souza-Smith FM
Am J Physiol Cell Physiol; 2021 Jul; 321(1):C104-C116. PubMed ID: 33909502
[TBL] [Abstract][Full Text] [Related]
7. Mdia1 is Crucial for Advanced Glycation End Product-Induced Endothelial Hyperpermeability.
Zhou X; Weng J; Xu J; Xu Q; Wang W; Zhang W; Huang Q; Guo X
Cell Physiol Biochem; 2018; 45(4):1717-1730. PubMed ID: 29490301
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-β.
Shao B; Bayraktutan U
Diabetes Obes Metab; 2013 Nov; 15(11):993-9. PubMed ID: 23617822
[TBL] [Abstract][Full Text] [Related]
9. TGFβ1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5.
McMillin MA; Frampton GA; Seiwell AP; Patel NS; Jacobs AN; DeMorrow S
Lab Invest; 2015 Aug; 95(8):903-13. PubMed ID: 26006017
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end-products disrupt the blood-brain barrier by stimulating the release of transforming growth factor-β by pericytes and vascular endothelial growth factor and matrix metalloproteinase-2 by endothelial cells in vitro.
Shimizu F; Sano Y; Tominaga O; Maeda T; Abe MA; Kanda T
Neurobiol Aging; 2013 Jul; 34(7):1902-12. PubMed ID: 23428182
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro.
Hoffmann S; Friedrichs U; Eichler W; Rosenthal A; Wiedemann P
Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):996-1002. PubMed ID: 12483322
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases 2 and 9 increase permeability of sheep pleura in vitro.
Apostolidou E; Paraskeva E; Gourgoulianis K; Molyvdas PA; Hatzoglou C
BMC Physiol; 2012 Mar; 12():2. PubMed ID: 22424238
[TBL] [Abstract][Full Text] [Related]
13. Heparanase-driven inflammation from the AGEs-stimulated macrophages changes the functions of glomerular endothelial cells.
Xu G; Qin Q; Yang M; Qiao Z; Gu Y; Niu J
Diabetes Res Clin Pract; 2017 Feb; 124():30-40. PubMed ID: 28081450
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
[TBL] [Abstract][Full Text] [Related]
15. Lipid rafts regulate PCB153-induced disruption of occludin and brain endothelial barrier function through protein phosphatase 2A and matrix metalloproteinase-2.
Eum SY; Jaraki D; András IE; Toborek M
Toxicol Appl Pharmacol; 2015 Sep; 287(3):258-66. PubMed ID: 26080028
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of advanced glycation end-products-induced retinal vascular permeability by silver nanoparticles.
Sheikpranbabu S; Kalishwaralal K; Lee KJ; Vaidyanathan R; Eom SH; Gurunathan S
Biomaterials; 2010 Mar; 31(8):2260-71. PubMed ID: 19963272
[TBL] [Abstract][Full Text] [Related]
17. Endothelial Tight Junctions Are Opened in Cholinergic-Evoked Salivation In Vivo.
Cong X; Zhang Y; He QH; Wei T; Zhang XM; Zhang JZ; Xiang RL; Yu GY; Wu LL
J Dent Res; 2017 May; 96(5):562-570. PubMed ID: 28118553
[TBL] [Abstract][Full Text] [Related]
18. Roundabout 4 regulates blood-tumor barrier permeability through the modulation of ZO-1, Occludin, and Claudin-5 expression.
Cai H; Liu W; Xue Y; Shang X; Liu J; Li Z; Wang P; Liu L; Hu Y; Liu Y
J Neuropathol Exp Neurol; 2015 Jan; 74(1):25-37. PubMed ID: 25470344
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its effects on occludin, zonula occludens-1, and claudin-11.
Lui WY; Lee WM; Cheng CY
Endocrinology; 2001 May; 142(5):1865-77. PubMed ID: 11316752
[TBL] [Abstract][Full Text] [Related]
20. Cadmium exposure inhibits MMP2 and MMP9 activities in the prostate and testis.
Lacorte LM; Rinaldi JC; Justulin LA; Delella FK; Moroz A; Felisbino SL
Biochem Biophys Res Commun; 2015 Feb; 457(4):538-41. PubMed ID: 25600809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]